These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 22511091

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Visceral leishmaniasis treatment in the Indian subcontinent: how to reach the most vulnerable.
    Picado A, Rijal S, Sundar S, Boelaert M.
    Expert Rev Anti Infect Ther; 2012 Aug; 10(8):839-41. PubMed ID: 23030320
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Increasing failure of miltefosine in the treatment of Kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance.
    Rijal S, Ostyn B, Uranw S, Rai K, Bhattarai NR, Dorlo TP, Beijnen JH, Vanaerschot M, Decuypere S, Dhakal SS, Das ML, Karki P, Singh R, Boelaert M, Dujardin JC.
    Clin Infect Dis; 2013 Jun; 56(11):1530-8. PubMed ID: 23425958
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Visceral leishmaniasis: a rare cause of post-transplant fever and pancytopenia.
    Rajaram KG, Sud K, Kohli HS, Gupta KL, Sakhuja V.
    J Assoc Physicians India; 2002 Jul; 50():979-80. PubMed ID: 12126362
    [Abstract] [Full Text] [Related]

  • 7. Oral miltefosine in the treatment of kala-azar.
    Mohan A, Seth S.
    Natl Med J India; 2000 Jul; 13(4):202-3. PubMed ID: 11002688
    [No Abstract] [Full Text] [Related]

  • 8. Lymphatic leishmaniasis--first case report from Nepal.
    Sharma SK, Das ML, Rijal S, Sah SP, Koirala S.
    Southeast Asian J Trop Med Public Health; 2001 Dec; 32(4):749-50. PubMed ID: 12041549
    [Abstract] [Full Text] [Related]

  • 9. Relapse of visceral leishmaniasis after miltefosine treatment in a Nepalese patient.
    Pandey BD, Pandey K, Kaneko O, Yanagi T, Hirayama K.
    Am J Trop Med Hyg; 2009 Apr; 80(4):580-2. PubMed ID: 19346379
    [Abstract] [Full Text] [Related]

  • 10. Breakthrough in the management of visceral leishmaniasis.
    Thakur BB.
    J Assoc Physicians India; 2003 Jul; 51():649-51. PubMed ID: 14621030
    [No Abstract] [Full Text] [Related]

  • 11. Immune response following miltefosine therapy in a patient with post-kala-azar dermal leishmaniasis.
    Ansari NA, Ramesh V, Salotra P.
    Trans R Soc Trop Med Hyg; 2008 Nov; 102(11):1160-2. PubMed ID: 18639311
    [Abstract] [Full Text] [Related]

  • 12. Holiday souvenirs from the Mediterranean: three instructive cases of visceral leishmaniasis.
    Buonomano R, Brinkmann F, Leupin N, Boscacci R, Zimmermann A, Müller N, Fux CA.
    Scand J Infect Dis; 2009 Nov; 41(10):777-81. PubMed ID: 19593691
    [Abstract] [Full Text] [Related]

  • 13. Oral miltefosine treatment in children with mild to moderate Indian visceral leishmaniasis.
    Sundar S, Jha TK, Sindermann H, Junge K, Bachmann P, Berman J.
    Pediatr Infect Dis J; 2003 May; 22(5):434-8. PubMed ID: 12792385
    [Abstract] [Full Text] [Related]

  • 14. The hunt for an elusive source of pyrexia in a foreign worker.
    Lew JW, Koh CK, Selvan VS, Shen E.
    Singapore Med J; 2007 Apr; 48(4):e111-3. PubMed ID: 17384865
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Short-course of oral miltefosine for treatment of visceral leishmaniasis.
    Sundar S, Makharia A, More DK, Agrawal G, Voss A, Fischer C, Bachmann P, Murray HW.
    Clin Infect Dis; 2000 Oct; 31(4):1110-3. PubMed ID: 11049800
    [Abstract] [Full Text] [Related]

  • 18. Treatment of Leishmania donovani-infected hamsters with miltefosine: analysis of cytokine mRNA expression by real-time PCR, lymphoproliferation, nitrite production and antibody responses.
    Gupta R, Kushawaha PK, Samant M, Jaiswal AK, Baharia RK, Dube A.
    J Antimicrob Chemother; 2012 Feb; 67(2):440-3. PubMed ID: 22121191
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Hypersensitivity reaction over lesions of post-kala-azar dermal leishmaniasis mimicking type 1 reaction in leprosy.
    Dhar S, Malakar S.
    Int J Lepr Other Mycobact Dis; 1999 Mar; 67(1):66-7. PubMed ID: 10407631
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.